Kyle Haraldsen
Nessuna posizione attualmente
Storia della carriera di Kyle Haraldsen
Precedenti posizioni note di Kyle Haraldsen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
| SANA AB | Corporate Officer/Principal | 01/01/2021 | - |
Formazione di Kyle Haraldsen
| Northeastern University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Danimarca | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SANA AB | Health Technology |
| Aziende private | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Kyle Haraldsen
- Esperienza
